1. Symptom-to-Balloon Time is a Strong Predictor of Adverse Events Following Primary Percutaneous Coronary Intervention: Results From the Australian Capital Territory PCI Registry 
Jaya Chandrasekhar, MBBS, Paul Marley, Dip App Sci, Christopher Allada, MBBS, Darryl McGill, MBBS, PhD, Simon O’Connor, MBBS, Moyazur Rahman, MBBS, Ren Tan, MBBS, Ata Doost Hosseiny, MD, Bruce Shadbolt, PhD, Ahmad Farshid, BMBS 
Heart, Lung and Circulation 
Volume 26, Issue 1, Pages (January 2017)
DOI: /j.hlc
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

2. Figure 1 Study Flow for 1002 primary PCI patients.
Heart, Lung and Circulation  , 41-48DOI: ( /j.hlc )
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

3. Figure 2
Kaplan-Meier analysis for MACE-free survival stratified by symptom-to-balloon time (≤240 and >240minutes). MACE refers to major adverse cardiac events, a composite of death, reinfarction, stent thrombosis and target vessel revascularisation.
Heart, Lung and Circulation  , 41-48DOI: ( /j.hlc )
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

4. Figure 3
Incidence of 1 year major adverse cardiac events (MACE) by symptom-to-balloon time (minutes). MACE was a composite of death, reinfarction, stent thrombosis and target vessel revascularisation.
Heart, Lung and Circulation  , 41-48DOI: ( /j.hlc )
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

5. Figure 4
Analysis of components of treatment times in subgroups with prolonged symptom-to-balloon times compared with the reference group
Treatment times are in minutes and presented as medians; FMC, first medical contact.
Heart, Lung and Circulation  , 41-48DOI: ( /j.hlc )
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions